Been following this stock for a little while now and this announcement doesn't convince me...
Firstly I want to see the p scores for the other testing days not just after 50 days and 36 days when it was statistically significant.
Additionally, I don't want them to arbitrarily pick a 50% pain reduction level and then manipulate the statistical results as people above have mentioned.
Some might think I'm being picky, but I would also like to see lower p values. If this drug is really as valuable as they are claiming I would have thought the results would have at least been statistically significant at the 99% level.
Anyway, that's my 2 cents but the company is going to have to release more data in order to get me over the line
Ann: PAR Reports Successful Phase 2 Clinical Trial, page-19
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.5¢ |
Change
0.080(16.2%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 58.0¢ | 50.0¢ | $753.7K | 1.388M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3168 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 102000 | 2 |
View Market Depth
| Last trade - 12.31pm 04/12/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
